(19Z)-1,4-Dimethyl-3,21α-cyclo-3,4-secosarpagan-17-ol (65910-35-2)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 4-Hydroxy-5-(hydroxyimino)-6α,21α-cyclo-4,5-secoakuammilan-17-oic acid methyl ester
- (19Z)-1-Acetyl-19,20-didehydro-17-hydroxy-10,11-dimethoxy-4-methyl-3,4-secocuran-3-one
- (19Z)-4-methylsarpagan-4-ium-17-ol chloride
- 3,21-Cyclo-3,4-secosarpagan
- 3α,5-Epidioxy-3-isopropyl-23,24-dinor-4-oxagammaceran-21α-ol
- (19Z)-Sarpagan-17-ol
- 16,24-Cyclo-21-norchol-4-en-3-one, 17-acetyl-6-methyl-, (6alpha,16beta,17alpha)-, mixt. with (17alpha)-3-methoxy-19-norpregna-1,3,5(10)-trien-20-yn-17-ol
- Sarpagan-17-ol,(16S,19Z)-
- (2ξ)-1-Acetyl-4,5-bis(acetyloxy)-1,2-dihydro-6α,21α-cyclo-4,5-secoakuammilan-17-oic acid methyl ester
- methyl (19Z)-3-ibogamin-12-ylvobasan-17-oate
- 16,24-Cyclo-21-norchol-4-en-3-one,17-acetyl-6-methyl-, (6a,16b,17a)-
- (19Z,21E,23E,25E,27E,29E,31E)-33-[(3-amino-3,6-dideoxy-4-O-hexopyranosylhexopyranosyl)oxy]-1,3,5,7,9,11,13,37-octahydroxy-17-{4-hydroxy-1-methyl-6-[4-(methylamino)phenyl]-6-oxohexyl}-18-methyl-15-oxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,
- 3,6,9,12,15-Pentaoxaheptadecan-1-ol,17-(3-chloro-4-cyclohexylphenoxy)-
- methyl (19Z,21E,23E,25E,27E,29E,31E)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-17-[6-(4-aminophenyl)-4-hydroxy-1-methyl-6-oxohexyl]-1,3,5,7,9,13,37-heptahydroxy-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-h
- (5S)-5-(Acetyloxy)-4,5-epoxy-6α,21α-cyclo-4,5-secoakuammilan-17-oic acid methyl ester
- 4,5-Bis(acetyloxy)-6α,21α-cyclo-4,5-secoakuammilan-17-oic acid methyl ester
- (2ξ)-1,2-Dihydro-4,5-dihydroxy-6α,21α-cyclo-4,5-secoakuammilan-17-oic acid methyl ester
- (5S)-4,5-Epoxy-5-methoxy-6α,21α-cyclo-4,5-secoakuammilan-17-oic acid methyl ester
- 3-Methoxy-17-methylmorphinan-4-ol
- 15,19-Hexatriacontadiene-1,11-diyn-3-ol, (3R,15Z,19Z)-